CSET’s Jacob Feldgoise shared his expert analysis in an article published by BBC. The article discusses the U.S. government’s 10% stake in Intel, highlighting the move as part of broader efforts to strengthen domestic semiconductor production and maintain U.S. technological leadership.

CSET’s Jacob Feldgoise shared his expert analysis in an article published by Bloomberg. The article discusses a controversial revenue-sharing deal in which Nvidia and AMD agreed to pay 15% of their Chinese AI chip sales to the U.S. government, highlighting how the Trump administration has softened export controls in exchange for financial concessions.

Jacob Feldgoise and Hanna Dohmen shared their expert insights in an article published by Bloomberg. The article discusses China’s ongoing struggle to develop advanced semiconductor lithography systems—technology crucial to its ambitions for technological self-sufficiency amid its trade and tech rivalry with the United States.

CSET’s Helen Toner shared her expert insights in an article published by Foreign Policy. The article explores the impact of renewed U.S. export restrictions on Nvidia and the broader implications for U.S.-China competition in artificial intelligence (AI). Nvidia announced it expects a $5.5 billion financial hit due to new licensing requirements for selling its H20 chips to China.

CSET's Steph Batalis shared her expert analysis in an op-ed published by DefenseOne. In her piece, she highlights how the United States’ faltering response to the ongoing measles outbreak reveals serious vulnerabilities in the nation’s public health and biodefense infrastructure.

A CSET report and data snapshot was highlighted in an article published by Rest of World. The article explores China’s growing efforts to build a self-sufficient semiconductor industry amid tightening U.S. export restrictions.

Jack Corrigan and Vikram Venkatram shared their expert analysis in an op-ed published by The National Interest. In their piece, they examine the political and legal controversy surrounding the Biden administration’s draft guidance on “march-in rights” under the Bayh-Dole Act, which could allow federal agencies to lower drug prices by reclaiming patents on taxpayer-funded inventions when they are not reasonably accessible to the public.

CSET's Steph Batalis and Vikram Venkatram shared their expert analysis in an op-ed published by The Bulletin of the Atomic Scientists. The article explores discusses the complexities and challenges of screening DNA synthesis orders to prevent misuse of potentially dangerous genetic sequences.

Hannah Dohmen was featured in an article published by the South China Morning Post, which covered testimony before the US-China Economic and Security Review Commission (USCC).

In a segment in the Lawfare Marketplace Morning Report, Jacob Feldgoise provides his expert analysis on the escalating trade tensions between the U.S. and China.